Cite

MLA Citation

    B. Tamjid et al.. “3218 PACEBOM in relapsed/refractory (R/R) lymphoma in the rituximab (R) era.” European journal of cancer, vol. 51, n.d., pp. S655–. http://access.bl.uk/ark:/81055/vdc_100030628321.0x000029
  
Back to record